Simvastatin & MS

Today’s news is relayed courtesy of Shine On Scotland:

“High-dose simvastatin (Zocor) significantly reduced brain atrophy and slowed advancement of disability for 2 years in patients with secondary progressive multiple sclerosis, researchers said here…

On the other hand, differences between the treatment groups in specific functional outcomes, such as walking ability and hand dexterity, did not reach statistical significance…

Because statin drugs have a range of anti-inflammatory effects, apart from their cholesterol-lowering activity, they have attracted attention as a possible therapy for MS.”

The overlap between the benefits of statins and vitamin D is abundantly clear as detailed in my book. However, statins do not appear to do a highly effective job.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s